JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 14, 2006; DOI: 10.1124/jpet.106.106757


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.106757v1
318/3/1006    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Jens D Mikkelsen
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hansen, H. H
Right arrow Articles by Mikkelsen, J. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hansen, H. H
Right arrow Articles by Mikkelsen, J. D


Received for publication May 4, 2006.
Revised June 13, 2006.
Accepted for publication June 13, 2006.

The KCNQ opener Retigabine Inhibits the Activity of Mesencephalic Dopaminergic Systems of the Rat

Henrik H Hansen 1, Christina Ebbesen 1, Claus Mathiesen 1, Pia Weikop 1, Lars-Christian Ronn 1, Olivier Waroux 2, Jacqueline Scuvee-Moreau 2, Vincent Seutin 2, Jens D Mikkelsen 3*

1 Neurosearch A/S 2 University of Liege 3 NeuroSearch A/S

* Address correspondence to: E-mail: jdm{at}neurosearch.dk

Abstract

Homo- and heteromeric complexes of KCNQ subunits are the molecular correlate of the M-current, a neuron-specific voltage-dependent K+ current with a well-established role in control of neural excitability. We investigated the effect of KCNQ channel modulators on the activity of dopaminergic neurons in vitro and in vivo in the rat ventral mesencephalon. The firing of dopaminergic neurons recorded in mesencephalic slices was robustly inhibited in a concentration-dependent manner by the KCNQ opener, retigabine. The effect of retigabine persisted in the presence of tetrodotoxin and simultanous blockade of GABAA receptors, SK and Ih channels, and was potently reversed by the KCNQ channel blocker XE991, indicating a direct effect on KCNQ channels. Similarly, in vivo single unit recordings from dopaminergic neurons revealed a prominent reduction in spike activity after systemic administration of retigabine. Furthermore, retigabine inhibited dopamine synthesis and c-Fos expression in the striatum under basal conditions. Retigabine completely blocked the excitatory effect of dopamine D2 autoreceptor antagonists. Again, the in vitro and in vivo effects of retigabine were completely reversed by pre-administration of XE991. Dual-immunocytochemistry revealed that KCNQ4 is the major KCNQ subunit expressed in all dopaminergic neurons in the mesolimbic and nigrostriatal pathways. Collectively, these observations indicate that retigabine negatively modulates dopaminergic neurotransmission, likely originating from stimulation of mesencephalic KCNQ4 channels.


Key words: Basal ganglia, Dopamine, KCNQ, M-current, Retigabine, Substantia nigra


This article has been cited by other articles:


Home page
J. Physiol.Home page
H. H. Hansen, O. Waroux, V. Seutin, T. J. Jentsch, S. Aznar, and J. D. Mikkelsen
Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS
J. Physiol., April 1, 2008; 586(7): 1823 - 1832.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
H. S. Jensen, M. Grunnet, and S.-P. Olesen
Inactivation as a New Regulatory Mechanism for Neuronal Kv7 Channels
Biophys. J., April 15, 2007; 92(8): 2747 - 2756.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
S. Koyama, M. S. Brodie, and S. B. Appel
Ethanol Inhibition of M-Current and Ethanol-Induced Direct Excitation of Ventral Tegmental Area Dopamine Neurons
J Neurophysiol, March 1, 2007; 97(3): 1977 - 1985.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.